Transduction of human primitive repopulating hematopoietic cells with lentiviral vectors pseudotyped with various envelope proteins

Molecular Therapy

Volumn 18, Issue 7, 2010, Pages 1310-1317

  Kim, Yoon Sang ^a   Wielgosz, Matthew M ^a   Hargrove, Phillip ^a   Kepes, Steven ^b   Gray, John ^a   Persons, Derek A ^a   Nienhuis, Arthur W ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Medtronic Spinal and Biologics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTROPIC MURINE LEUKEMIA VIRUS ENVELOP PROTEIN; FELINE LEUKEMIA VIRAL ENVELOPE PROTEIN; FELINE LEUKEMIA VIRUS TYPE C ENVELOPE PROTEIN; GENOMIC RNA; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VESICULAR STOMATITIS VIRUS ENVELOPE GLYCOPROTEIN; VIRUS ENVELOPE PROTEIN;

ARTICLE; BONE MARROW CELL; CD34 SELECTION; CELL BASED GENE THERAPY; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; ENGRAFTMENT; FEMALE; GENETIC TRANSDUCTION; HELA CELL; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; SEX DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRUS TITRATION;

ANIMALS; ANTIGENS, CD34; CELL LINE; GENETIC VECTORS; HELA CELLS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, FELINE; LEUKEMIA VIRUS, MURINE; MEMBRANE GLYCOPROTEINS; MICE; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS;

AMPHOTROPIC MURINE LEUKEMIA VIRUS; FELIDAE; FELINE LEUKEMIA VIRUS; MUS; VESICULAR STOMATITIS VIRUS;

EID: 77954242823     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2010.48     Document Type: Article

References (51)

1. Nienhuis, AW (2008). Development of gene therapy for blood disorders. Blood 111: 4431-4444.
2. Cavazzana-Calvo, M, Hacein-Bey, S, de Saint Basile, G, Gross, F, Yvon, E, Nusbaum, P et al. (2000). Gene therapy of human severe combined immunodefciency (SCID)-X1 disease. Science 288: 669-672. (Pubitemid 30241569)
3. Aiuti, A, Slavin, S, Aker, M, Ficara, F, Deola, S, Mortellaro, A et al. (2002). Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning. Science 296: 2410-2413.
4. Gaspar, HB, Parsley, KL, Howe, S, King, D, Gilmour, KC, Sinclair, J et al. (2004). Gene therapy of X-linked severe combined immunodefciency by use of a pseudotyped gammaretroviral vector. Lancet 364: 2181-2187.
5. Sadelain, M, Boulad, F, Lisowki, L, Moi, P and Riviere, I (2008). Stem cell engineering for the treatment of severe hemoglobinopathies. Curr Mol Med 8: 690-697.
6. May, C, Rivella, S, Callegari, J, Heller, G, Gaensler, KM, Luzzatto, L et al. (2000). Therapeutic haemoglobin synthesis in β-thalassaemic mice expressing lentivirus-encoded human β-globin. Nature 406: 82-86.
7. Levasseur, DN, Ryan, TM, Pawlik, KM and Townes, TM (2003). Correction of a mouse model of sickle cell disease: lentiviral/antisickling β-globin gene transduction of unmobilized, purifed hematopoietic stem cells. Blood 102: 4312-4319.
8. Zhao, H, Pestina, TI, Nasimuzzaman, M, Mehta, P, Hargrove, PW and Persons, DA (2009). Amelioration of murine β-thalassemia through drug selection of hematopoietic stem cells transduced with a lentiviral vector encoding both γ-globin and the MGMT drug-resistance gene. Blood 113: 5747-5756.
9. Pestina, TI, Hargrove, PW, Jay, D, Gray, JT, Boyd, KM and Persons, DA (2009). Correction of murine sickle cell disease using γ-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Mol Ther 17: 245-252.
10. Frecha, C, Szécsi, J, Cosset, FL and Verhoeyen, E (2008). Strategies for targeting lentiviral vectors. Curr Gene Ther 8: 449-460.
11. Naldini, L, Blömer, U, Gallay, P, Ory, D, Mulligan, R, Gage, FH et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
12. Guenechea, G, Gan, OI, Inamitsu, T, Dorrell, C, Pereira, DS, Kelly, M et al. (2000). Transduction of human CD34+ CD38-bone marrow and cord blood-derived SCID-repopulating cells with third-generation lentiviral vectors. Mol Ther 1: 566-573.
13. Liu, Y, Hangoc, G, Campbell, TB, Goodman, M, Tao, W, Pollok, K et al. (2008). Identifcation of parameters required for effcient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells. Exp Hematol 36: 947-956.
14. Tesio, M, Gammaitoni, L, Gunetti, M, Leuci, V, Pignochino, Y, Jordaney, N et al. (2008). Sustained long-term engraftment and transgene expression of peripheral blood CD34+ cells transduced with third-generation lentiviral vectors. Stem Cells 26: 1620-1627.
15. Benhamida, S, Pfumio, F, Dubart-Kupperschmitt, A, Zhao-Emonet, JC, Cavazzana-Calvo, M, Rocchiccioli, F et al. (2003). Transduced CD34+ cells from adrenoleukodystrophy patients with HIV-derived vector mediate long-term engraftment of NOD/SCID mice. Mol Ther 7: 317-324.
16. Throm, RE, Ouma, AA, Zhou, S, Chandrasekaran, A, Lockey, T, Greene, M et al. (2009). Effcient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfection. Blood 113: 5104-5110.
17. Broussau, S, Jabbour, N, Lachapelle, G, Durocher, Y, Tom, R, Transfguracion, J et al. (2008). Inducible packaging cells for large-scale production of lentiviral vectors in serum-free suspension culture. Mol Ther 16: 500-507.
18. Hanawa, H, Kelly, PF, Nathwani, AC, Persons, DA, Vandergriff, JA, Hargrove, P et al. (2002). Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood. Mol Ther 5: 242-251.
19. Hanawa, H, Hematti, P, Keyvanfar, K, Metzger, ME, Krouse, A, Donahue, RE et al. (2004). Effcient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodefciency virus-based lentiviral vector system. Blood 103: 4062-4069.
20. Kim, YJ, Kim, YS, Larochelle, A, Renaud, G, Wolfsberg, TG, Adler, R et al. (2009). Sustained high-level polyclonal hematopoietic marking and transgene expression 4 years after autologous transplantation of rhesus macaques with SIV lentiviral vector-transduced CD34+ cells. Blood 113: 5434-5443.
21. Mazurier, F, Gan, OI, McKenzie, JL, Doedens, M and Dick, JE (2004). Lentivector-mediated clonal tracking reveals intrinsic heterogeneity in the human hematopoietic stem cell compartment and culture-induced stem cell impairment. Blood 103: 545-552.
22. Kelly, PF, Vandergriff, J, Nathwani, A, Nienhuis, AW and Vanin, EF (2000). Highly effcient gene transfer into cord blood nonobese diabetic/severe combined immunodefciency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. Blood 96: 1206-1214.
23. Sandrin, V, Boson, B, Salmon, P, Gay, W, Nègre, D, Le Grand, R et al. (2002). Lentiviral vectors pseudotyped with a modifed RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates. Blood 100: 823-832.
24. Lucas, ML, Seidel, NE, Porada, CD, Quigley, JG, Anderson, SM, Malech, HL et al. (2005). Improved transduction of human sheep repopulating cells by retrovirus vectors pseudotyped with feline leukemia virus type C or RD114 envelopes. Blood 106: 51-58.
25. Shultz, LD, Lyons, BL, Burzenski, LM, Gott, B, Chen, X, Chaleff, S et al. (2005). Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R γ null mice engrafted with mobilized human hemopoietic stem cells. J Immunol 174: 6477-6489.
26. Strom, TS, Gabbard, W, Kelly, PF, Cunningham, JM and Nienhuis, AW (2003). Functional correction of T cells derived from patients with the Wiskott-Aldrich syndrome (WAS) by transduction with an oncoretroviral vector encoding the WAS protein. Gene Ther 10: 803-809.
27. Strom, TS, Turner, SJ, Andreansky, S, Liu, H, Doherty, PC, Srivastava, DK et al. (2003). Defects in T-cell-mediated immunity to infuenza virus in murine Wiskott-Aldrich syndrome are corrected by oncoretroviral vector-mediated gene transfer into repopulating hematopoietic cells. Blood 102: 3108-3116.
28. Trobridge, GD, Beard, BC, Gooch, C, Wohlfahrt, M, Olsen, P, Fletcher, J et al. (2008). Effcient transduction of pigtailed macaque hematopoietic repopulating cells with HIV-based lentiviral vectors. Blood 111: 5537-5543.
29. Leurs, C, Jansen, M, Pollok, KE, Heinkelein, M, Schmidt, M, Wissler, M et al. (2003). Comparison of three retroviral vector systems for transduction of nonobese diabetic/severe combined immunodefciency mice repopulating human CD34+ cord blood cells. Hum Gene Ther 14: 509-519.
30. Relander, T, Johansson, M, Olsson, K, Ikeda, Y, Takeuchi, Y, Collins, M et al. (2005). Gene transfer to repopulating human CD34+ cells using amphotropic-, GALV-or RD114-pseudotyped HIV-1-based vectors from stable producer cells. Mol Ther 11: 452-459.
31. Di Nunzio, F, Piovani, B, Cosset, FL, Mavilio, F and Stornaiuolo, A (2007). Transduction of human hematopoietic stem cells by lentiviral vectors pseudotyped with the RD114-TR chimeric envelope glycoprotein. Hum Gene Ther 18: 811-820.
32. Kiem, HP, Heyward, S, Winkler, A, Potter, J, Allen, JM, Miller, AD et al. (1997). Gene transfer into marrow repopulating cells: comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons. Blood 90: 4638-4645.
33. Hu, J, Kelly, P, Bonifacino, A, Agricola, B, Donahue, R, Vanin, E et al. (2003). Direct comparison of RD114-pseudotyped versus amphotropic-pseudotyped retroviral vectors for transduction of rhesus macaque long-term repopulating cells. Mol Ther 8: 611-617.
34. Takatoku, M, Sellers, S, Agricola, BA, Metzger, ME, Kato, I, Donahue, RE et al. (2001). Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 108: 447-455.
35. Sutton, RE, Reitsma, MJ, Uchida, N and Brown, PO (1999). Transduction of human progenitor hematopoietic stem cells by human immunodefciency virus type 1-based vectors is cell cycle dependent. J Virol 73: 3649-3660.
36. Lewis, PF and Emerman, M (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodefciency virus. J Virol 68: 510-516.
37. Haas, DL, Case, SS, Crooks, GM and Kohn, DB (2000). Critical factors infuencing stable transduction of human CD34(+) cells with HIV-1-derived lentiviral vectors. Mol Ther 2: 71-80.
38. Mezquita, P, Beard, BC and Kiem, HP (2008). NOD/SCID repopulating cells contribute only to short-term repopulation in the baboon. Gene Ther 15: 1460-1462.
39. Orlic, D, Girard, LJ, Jordan, CT, Anderson, SM, Cline, AP and Bodine, DM (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the effciency of retrovirus transduction. Proc Natl Acad Sci USA 93: 11097-11102.
40. Sabatino, DE, Do, BQ, Pyle, LC, Seidel, NE, Girard, LJ, Spratt, SK et al. (1997). Amphotropic or gibbon ape leukemia virus retrovirus binding and transduction correlates with the level of receptor mRNA in human hematopoietic cell lines. Blood Cells Mol Dis 23: 422-433.
41. Bertran, J, Miller, JL, Yang, Y, Fenimore-Justman, A, Rueda, F, Vanin, EF et al. (1996). Recombinant adeno-associated virus-mediated high-effciency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors. J Virol 70: 6759-6766.
42. Kurre, P, Kiem, H P, Morris, J, Heyward, S, Battini, JL and Miller, AD (1999). Effcient transduction by an amphotropic retrovirus vector is dependent on high-level expression of the cell surface virus receptor. J Virol 73: 495-500.
43. Relander, T, Brun, AC, Olsson, K, Pedersen, L and Richter, J (2002). Overexpression of gibbon ape leukemia virus (GALV) receptor (GLVR1) on human CD34(+) cells increases gene transfer mediated by GALV pseudotyped vectors. Mol Ther 6: 400-406.
44. Uckert, W, Willimsky, G, Pedersen, FS, Blankenstein, T and Pedersen, L (1998). RNA levels of human retrovirus receptors Pit1 and Pit2 do not correlate with infectibility by three retroviral vector pseudotypes. Hum Gene Ther 9: 2619-2627.
45. Brass, AL, Dykxhoorn, DM, Benita, Y, Yan, N, Engelman, A, Xavier, RJ et al. (2008). Identifcation of host proteins required for HIV infection through a functional genomic screen. Science 319: 921-926.
46. Wolf, D and Goff, SP (2008). Host restriction factors blocking retroviral replication. Annu Rev Genet 42: 143-163.
47. Schlegel, R, Tralka, TS, Willingham, MC and Pastan, I (1983). Inhibition of VSV binding and infectivity by phosphatidylserine: is phosphatidylserine a VSV-binding site? Cell 32: 639-646.
48. Schlegel, R and Wade, M (1983). Neutralized vesicular stomatitis virus binds to host cells by a different "receptor". Biochem Biophys Res Commun 114: 774-778.
49. Coil, DA and Miller, AD (2004). Phosphatidylserine is not the cell surface receptor for vesicular stomatitis virus. J Virol 78: 10920-10926.
50. Cartier, N, Hacein-Bey-Abina, S, Bartholomae, CC, Veres, G, Schmidt, M, Kutschera, I et al. (2009). Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science 326: 818-823.
51. Notta, F, Doulatov, S, and Dick, JE. (2010). Engraftment of human hematopoietic stem cells is more effcient in female NOD/SCID/IL-2Rgcnull recipients. Blood (epub ahead of print).